financetom
Business
financetom
/
Business
/
-- Boardwalk REIT Brief: Keeps Sector Perform, Target Raised To C$74 From $72 at National Bank Which Notes Q1 FFO Ahead On NOI Margins and G&A
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- Boardwalk REIT Brief: Keeps Sector Perform, Target Raised To C$74 From $72 at National Bank Which Notes Q1 FFO Ahead On NOI Margins and G&A
May 26, 2025 4:30 AM

02:25 PM EDT, 05/08/2025 (MT Newswires) --

Price: 66.05, Change: -0.16, Percent Change: -0.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eightco Launches Pilot Program for Enterprise AI Authentication; Shares Up Pre-Bell
Eightco Launches Pilot Program for Enterprise AI Authentication; Shares Up Pre-Bell
Oct 10, 2025
08:55 AM EDT, 10/10/2025 (MT Newswires) -- Eightco Holdings ( ORBS ) said Friday it launched a pilot program aimed at improving artificial intelligence authentication for enterprise clients. The company said the initiative will leverage investments, partnerships, and its Worldcoin treasury to develop a universal framework for digital identity and authentication. The program will help companies analyze single sign-on capabilities...
Oil Falls For Second Day As Israel-Gaza Ceasefire Eases Geopolitical Risk
Oil Falls For Second Day As Israel-Gaza Ceasefire Eases Geopolitical Risk
Oct 10, 2025
08:50 AM EDT, 10/10/2025 (MT Newswires) -- Oil prices eased early Friday, extending losses for a second day as traders priced in lower geopolitical risk following a U.S.-backed ceasefire in Israel's war on Gaza. West Texas Intermediate crude oil for November delivery was last seen down US$0.95 to $60.56 per barrel, while December Brent oil was down $0.97 to $64.25....
Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal
Bristol-Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal
Oct 10, 2025
08:55 AM EDT, 10/10/2025 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) on Friday agreed to acquire privately-held ribonucleic acid medication manufacturer Orbital Therapeutics in an all-cash deal worth about $1.5 billion, as it aims to boost its cell therapy portfolio. The transaction is expected to give Bristol Myers access to Orbital's lead pre-clinical candidate for chimeric antigen receptor T-cell...
Sector Update: Consumer
Sector Update: Consumer
Oct 10, 2025
08:53 AM EDT, 10/10/2025 (MT Newswires) -- Consumer stocks were steady pre-bell Friday, with the Consumer Staples Select Sector SPDR Fund (XLP) up a slight 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) unchanged. Levi Strauss (LEVI) shares were down more than 7% even after the company posted higher fiscal Q3 adjusted earnings and net revenue that beat...
Copyright 2023-2026 - www.financetom.com All Rights Reserved